| HealthPartners | Oncology - nivolumab (Opdivo®) – Minnesota Health | 2026-01-01 |
| HealthPartners | Oncology - pertuzumab, trastuzumab, and | 2026-01-01 |
| HealthPartners | Oncology - tafasitamab-cxix (Monjuvi®) – Minnesota | 2026-01-01 |
| HealthPartners | Oncology drug coverage | 2026-01-01 |
| HealthPartners | Oncology drug coverage – Minnesota Health Care | 2026-01-01 |
| HealthPartners | Oncology testing: algorithmic assays | 2026-01-01 |
| HealthPartners | Oncology testing: algorithmic assays – Minnesota | 2026-01-01 |
| HealthPartners | Pozelimab-bbfg (Veopoz™) | 2026-01-01 |
| HealthPartners | Reproductive testing: carrier screening | 2026-01-01 |
| HealthPartners | Reproductive testing: fertility | 2026-01-01 |